Barnick v. Wyeth

522 F. Supp. 2d 1257, 2007 U.S. Dist. LEXIS 86265, 2007 WL 4105411
CourtDistrict Court, C.D. California
DecidedOctober 25, 2007
DocketCV 07-3859 SVW (Ex)
StatusPublished
Cited by11 cases

This text of 522 F. Supp. 2d 1257 (Barnick v. Wyeth) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barnick v. Wyeth, 522 F. Supp. 2d 1257, 2007 U.S. Dist. LEXIS 86265, 2007 WL 4105411 (C.D. Cal. 2007).

Opinion

ORDER GRANTING DEFENDANT WYETH’S MOTION FOR SUMMARY JUDGMENT [20]

STEPHEN V. WILSON, District Judge.

I. Factual and Procedural Background

This is a uncertified class action by Plaintiff William Barnick (“Plaintiff’) against Defendants Wyeth and Does 1 to 50 alleging various wage-related claims. Defendant Wyeth (“Defendant”) develops, manufactures, and sells pharmaceutical products. (UF 1) On December 30, 1980, Plaintiff was hired by Defendant to its “sales staff’ as a pharmaceutical representative or a “territory manager.” (UF 5) The position required “a minimum of 1-2 years of selling experience.” (UF 15) The Plaintiff retired from this position voluntarily on February 28, 2006. (UF 78) During the time period relevant to this dispute, Plaintiff worked in Wyeth’s vaccine sales division in California. (UF 32) As part of this position, from May 9, 2003 to the end of his employment, Plaintiff visited or called upon physicians on a pre-as-signed list he created with Wyeth and discussed with these physicians various Wyeth pharmaceutical products, in particular vaccines Prevnar and FluMist and drugs Altace and ProtonixJBarnick Dee. at 6; Mills Dec. Ex. 1 at 76-79). In order to perform this work, Plaintiff spent 45-48 hours a week in the field. (UF 17).Plain-tiff was required to make a certain number of calls on selected doctors within a set period of time and additionally had a daily quota of calls he was required to make (Barnick Dec. at 6). Plaintiff was also expected to be working at least from 8:30 AM to 5:00 PM on weekdays, but stated in his deposition that no one at Wyeth controlled his hours. (Barnick Dec. at 5; Mills Dec. Ex. 1 at 67) Plaintiff was very rarely subject to any direct supervision, but was required to log his calls with physicians at the end of each working day, file weekly activity reports, check his voice mail three times a day, and computer synchronize once per day. (Barnick Dec. at 6)

Plaintiffs essential function was “to effect sales by educating and guiding health care professionals in their purchase and prescription of Wyeth’s products and by promoting treatment practices that are consistent with approved indications.” (UF 4) Wyeth expected Plaintiff to generate sales of their product. (UF 36) Plaintiff explained in his declaration that his “primary responsibility was to generate revenue for Wyeth by focusing on visiting specific doctors in my assigned territory to persuade them to prescribe the maximum number of vaccine doses or to prescribe pharmaceutical products to the greatest extent possible; my efforts were not aimed at promoting sales generally.” (Barnick Dec. at 5)

Plaintiff did not as a general matter directly sell any Wyeth products to physicians. Occasionally, Plaintiff provided order form’s to physicians to use to place orders from Wyeth for vaccines such as Prevnar and FluMist. Sometimes Plaintiff filled these order forms out for the physicians. If he did not have an order form *1259 with him, he gave the physician an 800 number to order vaccine dosages from Wyeth. (UF 50) Physicians would then order the vaccines from Wyeth and prescribe and administer the vaccines to patients directly at the physician’s office. (Barnick Decl. at 6) Plaintiff clarifies in his Declaration that he never provided order forms or information for Altace or Proto-nix. (Barnick Decl. at 8) Altace and Proto-nix were instead prescribed by physicians to patients who presumably ultimately purchased the drugs through a pharmacy. 1 (Barnick Dec. at 4-5)

Plaintiff was hired as a sales staff member by Wyeth and referred to himself as a salesperson in his deposition. (UF 7, 19-20) 2 Plaintiff was trained in sales techniques at numerous sales conferences throughout his employment where territory managers discussed sales data and sales strategies. (UF 11-13) In addition to a guaranteed yearly salary. Plaintiff received additional compensation tied to the number of sales of Wyeth’s products he assisted in generating. 3 (UF 8-10) Half of Plaintiffs total evaluation by Wyeth was based on his meeting sales objectives for Wyeth products. (UF 28) In Wyeth’s evaluation of Plaintiff, he was praised for his ability to “consistently close.” The evaluation also noted that the Plaintiff “consistently asks for business.” (Mills Dec. Ex. 8 at 218). In his deposition, Plaintiff admitted that he “asked for the business” during his calls and this was part of Wyeth’s selling strategy (Mills Dec. Ex. 1 at 59). However, in his later decla *1260 ration Plaintiff clarifies that he never took any commitments to prescribe Altace or Protonix (Barnick Dec. at 8). 4 Plaintiff did occasionally solicit new business for Wyeth by identifying new doctors in his territory to contact. (Mills Dec. Ex. 1 at 50-52)

Plaintiff filed this suit in California Superior Court on May 9, 2007 as a class action. Plaintiff alleges in his First through Fifth Causes of Action that Defendants failed to pay overtime wages as required by California Labor Code Section 510, failed to provide meal and rest breaks as required by California Labor Code Section 512, failed to itemize wage statements and accurately report total hours worked by Plaintiff in compliance with California Labor Code Section 226(a), and failed to pay waiting time wages under California Labor Code Section 203. In its Sixth Cause of Action, Plaintiff alleges unfair competition pursuant to Business and Professions Code Section 17200. (Plaintiff Comp, at 10-16) Defendant Wyeth removed the suit to federal court under the Class Action Fairness Act of 2005 and filed an answer on June 14, 2007.

Defendant Wyeth filed the present Motion for Summary Judgment on September 17, 2007. Defendant seeks summary judgment with regard to all of Plaintiffs claims on a number of grounds. However, the only ground that needs to be discussed in this memorandum is that Plaintiff was exempt from the relevant requirements of the California Labor Code because he was an “outside salesperson.” Defendant’s alternative ground that Plaintiff was exempt because his position was predominantly “administrative” need not be reached because Plaintiffs position is properly classified as that of an “outside salesperson.” Additionally, Plaintiff concedes that his Fourth Cause of Action under California Labor Code Section 226(a) is barred by the statute of limitations. (Plaintiff Opp. at 2 fn. 2)

As Plaintiff is properly classified as an exempt outside salesperson and has conceded his Fourth Cause of Action, Defendant’s Motion for Summary Judgment should be GRANTED-as to all of Plaintiffs claims.

II. Analysis

A. Standard for Summary Judgment

Rule 56(c) requires summary judgment for the moving party when the evidence, viewed in the light most favorable to the nonmoving party, shows that there is no genuine issue as to any material fact, and that the moving party is entitled to judgment as a matter of law. See Fed.R.Civ.P. 56(c); Tarin v. County of Los Angeles,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Martinez v. Superior HealthPlan, Inc.
371 F. Supp. 3d 370 (W.D. Texas, 2019)
Garnett v. ADT LLC
139 F. Supp. 3d 1121 (E.D. California, 2015)
Schaefer-LaRose v. Eli Lilly and Co.
663 F. Supp. 2d 674 (S.D. Indiana, 2009)
Baum v. ASTRAZENECA LP
605 F. Supp. 2d 669 (W.D. Pennsylvania, 2009)
Kuzinski v. Schering Corp.
604 F. Supp. 2d 385 (D. Connecticut, 2009)
In Re Novartis Wage and Hour Litigation
593 F. Supp. 2d 637 (S.D. New York, 2009)
Ruggeri v. Boehringer Ingelheim Pharmaceuticals, Inc.
585 F. Supp. 2d 308 (D. Connecticut, 2008)
Amendola v. Bristol-Myers Squibb Co.
558 F. Supp. 2d 459 (S.D. New York, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
522 F. Supp. 2d 1257, 2007 U.S. Dist. LEXIS 86265, 2007 WL 4105411, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barnick-v-wyeth-cacd-2007.